Abstract

AbstractNumerous non‐invasive assays have been developed to support CT imaging, consequently increasing the precision of diagnosis. Although these efforts made a significant contribution to clinical research, there is still more to be done. The goal is to replace conventional contrast agents with more potent ones. In this study, Ag−Au alloy nanoparticles were fabricated by substitution method between the precursor Au3+ and the previously prepared Ag nanoparticles. Effects of Au3+ quantity on the formation and characteristics of Ag−Au alloy nanoparticles were investigated. It showed that Ag−Au nanoalloy with a size of 14.2±1.0 nm, SPR absorption peak at 520 nm, and Ag: Au atomic ratio of approximately 3 : 1 were appropriate for biomedical applications. After phase transfer using poly (maleic anhydride‐alt‐1‐octadecene) (PMAO), the nano Ag−Au solution owned remarkable durability, stability and non‐toxicity Vero healthy cell line at high test concentration. In‐vitro CT imaging demonstrated a good X‐ray adsorption coefficient, and the hounsfield units (HU) was noticeably increased. As a promising CT contrast agent, the X‐ray attenuation of nano Ag−Au solutions correlated linearly with concentrations. These findings led to a potential application in the biomedical field, particularly in computed tomography (CT) imaging diagnosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call